January 13, 2016 16:51 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- The United State Food and Drug Administration (“FDA”) granted Elite Pharmaceuticals, Inc. (Elite or the “Company) (OTCBB:ELTP) a waiver of the application fee required for the filing of a New Drug Application (NDA).